Relevium’s CEO Issues Letter of Clarification to Shareholders
03 juil. 2019 10h03 HE
|
Relevium Technologies Inc
MONTREAL, July 03, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced today a letter from Aurelio...
Relevium Issues Statement Regarding Recent Promotional Activity
01 juil. 2019 16h24 HE
|
Relevium Technologies Inc
MONTREAL, July 01, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced today that it has been made aware...
Relevium’s Biocannabix Positions Itself as an Important Player in Colombia as it Pursues Endo-Medical Cannabis Strategy for Latin America
26 juin 2019 04h00 HE
|
Relevium Technologies Inc
MONTREAL, June 26, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. a Health and Wellness portfolio company listed on TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX” (the “Company” or...
Relevium to Hold Investor Call to Discuss LATAM Strategy June 28, 2019 at 1:00pm EST
19 juin 2019 08h30 HE
|
Relevium Technologies Inc
MONTREAL, June 19, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. a Health and Wellness portfolio company listed on TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX” (the “Company” or...
Relevium da un paso significativo en América Latina con la adquisición de Lifeline Pharma en Cali, Colombia
14 juin 2019 23h53 HE
|
Relevium Technologies Inc
MONTREAL, June 14, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” y Frankfurt: “6BX”) (la “Compañía” o “Relevium”), se complace en anunciar que Biocannabix Health...
Relevium Takes Major Step in Latam to Acquire Lifeline Pharma in Cali, Colombia
13 juin 2019 09h54 HE
|
Relevium Technologies Inc
MONTREAL, June 13, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that Biocannabix...
Relevium Closes Private Placement Financing
11 juin 2019 17h51 HE
|
Relevium Technologies Inc
MONTREAL, June 11, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that it has closed a...
Relevium’s Biocannabix Executes LOI to Acquire 30% Interest in Weedsense, a Late Stage Applicant for Standard Processing and Medical Sales License
05 juin 2019 09h46 HE
|
Relevium Technologies Inc
MONTREAL, June 05, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce its wholly owned...
Relevium Provides Corporate Update on Its Medical Cannabis Strategy
03 juin 2019 11h31 HE
|
Relevium Technologies Inc
MONTREAL, June 03, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide a corporate update on...
Relevium Acquires Exclusive Licence From California Based Cannakids®
30 mai 2019 08h00 HE
|
Relevium Technologies Inc
MONTREAL, May 30, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that its wholly owned...